Improving mental healthcare access and experience for people from minority ethnic groups: an England-wide multisite experience-based codesign (EBCD) study.


Journal

BMJ mental health
ISSN: 2755-9734
Titre abrégé: BMJ Ment Health
Pays: England
ID NLM: 9918521385306676

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 17 03 2023
accepted: 27 06 2023
medline: 21 7 2023
pubmed: 19 7 2023
entrez: 18 7 2023
Statut: ppublish

Résumé

Long-standing ethnic inequalities in access and mental healthcare were worsened by the COVID-19 pandemic. Stakeholders coproduced local and national implementation plans to improve mental healthcare for people from minority ethnic groups. Experience-based codesign conducted in four areas covered by National Health Service (NHS) mental health trusts: Coventry and Warwickshire, Greater Manchester, East London and Sheffield. Data were analysed using an interpretivist-constructivist approach, seeking validation from participants on their priority actions and implementation plans. Service users (n=29), carers (n=9) and health professionals (n=33) took part in interviews; focus groups (service users, n=15; carers, n=8; health professionals, n=24); and codesign workshops (service users, n=15; carers, n=5; health professionals, n=21) from July 2021 to July 2022. Each study site identified 2-3 local priority actions. Three were consistent across areas: (1) reaching out to communities and collaborating with third sector organisations; (2) diversifying the mental healthcare offer to provide culturally appropriate therapeutic approaches and (3) enabling open discussions about ethnicity, culture and racism. National priority actions included: (1) co-ordination of a national hub to bring about system level change and (2) recognition of the centrality of service users and communities in the design and provision of services. Stakeholder-led implementation plans highlight that substantial change is needed to increase equity in mental healthcare in England. Working with people with lived experience in leadership roles, and collaborations between NHS and community organisations will be essential. Future research avenues include comparison of the benefits of culturally specific versus generic therapeutic interventions.

Sections du résumé

BACKGROUND BACKGROUND
Long-standing ethnic inequalities in access and mental healthcare were worsened by the COVID-19 pandemic.
OBJECTIVES OBJECTIVE
Stakeholders coproduced local and national implementation plans to improve mental healthcare for people from minority ethnic groups.
METHODS METHODS
Experience-based codesign conducted in four areas covered by National Health Service (NHS) mental health trusts: Coventry and Warwickshire, Greater Manchester, East London and Sheffield. Data were analysed using an interpretivist-constructivist approach, seeking validation from participants on their priority actions and implementation plans. Service users (n=29), carers (n=9) and health professionals (n=33) took part in interviews; focus groups (service users, n=15; carers, n=8; health professionals, n=24); and codesign workshops (service users, n=15; carers, n=5; health professionals, n=21) from July 2021 to July 2022.
FINDINGS RESULTS
Each study site identified 2-3 local priority actions. Three were consistent across areas: (1) reaching out to communities and collaborating with third sector organisations; (2) diversifying the mental healthcare offer to provide culturally appropriate therapeutic approaches and (3) enabling open discussions about ethnicity, culture and racism. National priority actions included: (1) co-ordination of a national hub to bring about system level change and (2) recognition of the centrality of service users and communities in the design and provision of services.
CONCLUSIONS CONCLUSIONS
Stakeholder-led implementation plans highlight that substantial change is needed to increase equity in mental healthcare in England.
CLINICAL IMPLICATIONS CONCLUSIONS
Working with people with lived experience in leadership roles, and collaborations between NHS and community organisations will be essential. Future research avenues include comparison of the benefits of culturally specific versus generic therapeutic interventions.

Identifiants

pubmed: 37463794
pii: bmjment-2023-300709
doi: 10.1136/bmjment-2023-300709
pmc: PMC10357761
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMJ Open. 2020 Mar 5;10(3):e035121
pubmed: 32139493
Lancet Psychiatry. 2020 Sep;7(9):813-824
pubmed: 32682460
PLoS Med. 2022 Dec 13;19(12):e1004139
pubmed: 36512523
Lancet. 2022 Dec 10;400(10368):2023-2026
pubmed: 36502831
Health Expect. 2020 Jun;23(3):562-570
pubmed: 32045087
Traumatology (Tallahass Fla). 2021 Mar;27(1):60-69
pubmed: 34025223
BMJ. 2015 Jul 08;351:h3297
pubmed: 26157106
Am J Kidney Dis. 2020 Nov;76(5):679-689
pubmed: 32492463
Br J Psychiatry. 2020 Oct;217(4):543-546
pubmed: 32654678
Int J Environ Res Public Health. 2021 Mar 15;18(6):
pubmed: 33803942
Soc Psychiatry Psychiatr Epidemiol. 2021 Jun;56(6):1113
pubmed: 33839806

Auteurs

Catherine Winsper (C)

Research and Innovation, Caludon Centre, Coventry and Warwickshire Partnership Trust, Clifford Bridge Road, Coventry, UK.

Rahul Bhattacharya (R)

Tower Hamlets Home Treatment Team, East London NHS Foundation Trust, Robert Dolan House, Trust Headquarters, 9 Alie Street, London, UK.

Kamaldeep Bhui (K)

Department of Psychiatry, Medical Sciences Division, University of Oxford, Oxford, UK.
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Graeme Currie (G)

Warwick Business School, University of Warwick, Coventry, UK.

Dawn Edge (D)

Division of Psychology & Mental Health, G6 Coupland 1 Building, The University of Manchester, Manchester, UK.

David R Ellard (DR)

Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.
University Hospitals Coventry and Warwickshire, Coventry, UK.

Donna Franklin (D)

School of Health Sciences, Institute of Mental Health, University of Nottingham, Nottingham, UK.

Paramjit S Gill (PS)

Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.

Steve Gilbert (S)

Steve Gilbert Consulting, Suite 2A, Blackthorn House, St Pauls Square, Birmingham, UK.

Robin Miller (R)

School of Social Policy, University of Birmingham, Birmingham, UK.

Zahra Motala (Z)

Department of Sociology, University of Manchester, Manchester, UK.

Vanessa Pinfold (V)

McPin Foundation, 7-14 Great Dover Street, London, UK.

Harbinder Sandhu (H)

Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.

Swaran P Singh (SP)

Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.

Scott Weich (S)

School of Health and Related Research, The University of Sheffield, Sheffield, UK.

Domenico Giacco (D)

Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK domenico.giacco@warwick.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH